<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03948750</url>
  </required_header>
  <id_info>
    <org_study_id>COPILOT</org_study_id>
    <nct_id>NCT03948750</nct_id>
  </id_info>
  <brief_title>Immunoblotting and Goldmann-Witmer Coefficient for Ocular Toxoplasmosis</brief_title>
  <acronym>COPILOT</acronym>
  <official_title>Comparison of Immunoblotting (IgA and IgG) and the Goldmann-Witmer Coefficient for Diagnosis of Ocular Toxoplasmosis in Immunocompetent Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ocular toxoplasmosis (OT) is a common cause of posterior uveitis worldwide. The diagnosis of
      OT is based on clinical findings, but in most cases, laboratory tests are required to confirm
      the etiology, especially when other diseases are suspected. The aim of this study was to
      evaluate which methods, between the Goldmann-Witmer coefficient (GWC) and immunoblotting (IB)
      with both IgG and IgA, in aqueous humour (AH) samples, can be the most sensitive to diagnose
      OT, in current practice, especially in the first three weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Goldmann-Witmer coefficient (GWC): compares the levels of intraocular antibody (igG)
      production to that serum, as measured by ELISA.

      GWC = (Level of specific IgG in aqueous humour/level of specific IgG in serum)/(Total IgG in
      aqueous humour/Total IgG in serum)

      0.5 to 2: No intraocular antibody production, 2 to 4: Suggestive of intraocular antibody
      production, &gt; 4: Diagnostic of intraocular antibody production to a specific microbial
      pathogen
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2010</start_date>
  <completion_date type="Actual">May 31, 2014</completion_date>
  <primary_completion_date type="Actual">May 31, 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of Goldmann-Witmer coefficient and immunoblotting results</measure>
    <time_frame>Assessment of each test result at the inclusion of the patient</time_frame>
    <description>All tests realized in patients were performed before their repartition in the two groups as well as the biologist could not know the status of the patient. Sensitivity and specificity were calculated for each test.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">87</enrollment>
  <condition>Ocular Toxoplasmosis</condition>
  <arm_group>
    <arm_group_label>Patients with Ocular Toxoplasmosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without Ocular Toxoplasmosis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Aqueous humour sampling</intervention_name>
    <description>Aqueous humour sampling with Goldman-Witmer coefficient and immunoblotting</description>
    <arm_group_label>Patients with Ocular Toxoplasmosis</arm_group_label>
    <arm_group_label>Patients without Ocular Toxoplasmosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who had underwent aqueous humor and serum sample for ocular toxoplasmosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who had underwent aqueous humor and serum sample for ocular toxoplasmosis
             diagnosis

        Exclusion Criteria:

          -  Immunocompromised patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Service d'ophtalmologie, HÃ´pital de la Croix-Rousse (HCL)</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 10, 2019</study_first_submitted>
  <study_first_submitted_qc>May 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2019</study_first_posted>
  <last_update_submitted>May 10, 2019</last_update_submitted>
  <last_update_submitted_qc>May 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Toxoplasmosis</mesh_term>
    <mesh_term>Toxoplasmosis, Ocular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

